I was going to give the example but didn't have time. For example, when we got WinRho approved in 1980, the Province of Manitoba immediately switched from Johnson & Johnson's RhoGAM product to WinRho. Next was Saskatchewan, Alberta, Quebec—interestingly enough—and I think the last one was Ontario. Back then in the eighties, the provinces switched if there was a locally produced product.
There are many other examples where that could happen, but the health organizations have to look for them. There are not that many drugs now being developed in Canada, but other devices are. Another example is a Winnipeg imaging company called IMRIS, mobile MRI, which is now sold throughout the world. The last province, the last place to put one in, was Manitoba.
There isn't a mindset by the governments to do this, and part of it is because they don't recognize there are some that are locally made. There's a distance between the health buyers, and the second part of it is that they're being inundated by the sales people from Johnson & Johnson, etc., and being lobbied.
There has to be a deliberate attempt to look at procurement opportunities—and there are some. Start small and expand on them.